NASDAQEquity · Weekly research terminal

SCTX

Scribe Therapeutics Inc. Common Stock

US Healthcare Biotechnology

Latest week
14 Aug 2026
Weekly close
20.73 USD
Fair value
21.97 USD
Next-week expectancy
Positive 58.49%
Crowd view
Current verdict No votes yet Be first to vote

Sharemaestro
Weekly Chart Pack Completed weekly market data · Independent research

NASDAQ · Equity · United States

SCTX

Scribe Therapeutics Inc. Common Stock

Healthcare Biotechnology

None

Last updated
14 Aug 2026
Exchange
NASDAQ · NASDAQ
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Market capitalisation
391,059,000
Fair value reference
21.97
Next-week expectancy
Positive · 58.49%

Over the latest 12 completed weeks ending 2026-08-14, SCTX fell 4.25%, moving from 21.65 to 20.73. The latest weekly close is below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 4 weeks. Market Dynamics is 0.00 on the latest week. Next-week expectancy is positive at 58.49% based on similar historical setup states.

Week Ending
14 Aug 2026
Latest Close
20.73
12-Week Change
-4.25%
Trend Signal
Inactive
Next-Week Expectancy
Positive 58.49%
Signal Weeks
0 of 4

Weekly Price

Weekly Close Trend Line Fair Value Activity Lines

Chart Panels

Choose up to 5 panels. Drag panel headers to reorder.

Chart Summary

Key Points

Week Ending
14 Aug 2026
Latest Close
20.73
12-Week Change
-4.25%
Trend Signal
Inactive
Next-Week Expectancy
Positive 58.49%
Signal Weeks
0 of 4
Vs Fair Value
Below
Market Dynamics
0.00

Over the latest 12 completed weeks ending 2026-08-14, SCTX fell 4.25%, moving from 21.65 to 20.73. The latest weekly close is below Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 4 weeks. Market Dynamics is 0.00 on the latest week. Next-week expectancy is positive at 58.49% based on similar historical setup states.

Industry Peers

United States equities in Biotechnology

Stock Exchange Week Open High Low Close Change
LEXX Lexaria Bioscience Corp NASDAQ 14 Aug 2026 5.27 9.18 5.27 9.04 71.54%
INO Inovio Pharmaceuticals Inc NASDAQ 14 Aug 2026 0.66 1.10 0.66 1.09 65.15%
CAPR Capricor Therapeutics Inc NASDAQ 14 Aug 2026 4.04 8.15 3.73 6.65 64.60%
GRDX GridAI Technologies Corp. NASDAQ 14 Aug 2026 2.78 4.25 2.69 4.17 50.00%
MBRX Moleculin Biotech Inc NASDAQ 14 Aug 2026 0.42 0.64 0.40 0.61 45.83%
LIMN Liminatus Pharma, Inc. Class A Common Stock NASDAQ 14 Aug 2026 0.10 0.18 0.10 0.14 39.30%
APLM Apollomics Inc. Class A Ordinary Shares NASDAQ 14 Aug 2026 17.32 24.00 16.70 23.40 35.10%
NXTC NextCure  Inc NASDAQ 14 Aug 2026 6.16 8.72 5.91 8.21 33.28%
SION Sionna Therapeutics, Inc. Common Stock NASDAQ 14 Aug 2026 4.85 6.75 4.01 6.46 33.20%
DRMA Dermata Therapeutics Inc NASDAQ 14 Aug 2026 1.10 1.62 1.06 1.46 32.73%
VALN Valneva SE ADR NASDAQ 14 Aug 2026 5.40 7.31 5.20 7.13 32.04%
YDES YD Bio Ltd NASDAQ 14 Aug 2026 2.28 3.24 2.17 2.98 30.99%
ABCL Abcellera Biologics Inc NASDAQ 14 Aug 2026 8.76 11.50 8.40 11.38 29.91%
OMER Omeros Corporation NASDAQ 14 Aug 2026 13.36 18.14 13.00 17.19 28.67%
CAMP CAMP4 THERAPEUTICS CORPORATION NASDAQ 14 Aug 2026 4.25 5.48 4.09 5.44 28.00%
CUE Cue Biopharma NASDAQ 14 Aug 2026 27.39 34.61 24.80 34.20 24.86%

Next-week expectancy

Next-week expectancy is a short-term historical read. It compares the latest completed-week setup with broadly similar past setups and asks whether the following week tended to close higher or lower.

It is not a trend call, a price target, or a guarantee. A positive read can appear while price is below trend or activity pressure is weak, because it is measuring short-term follow-through odds for the current setup state.

Use it as one context layer beside Trend Line, Relative Strength, Market Dynamics, Fair Value, and the visible price structure.

Evidence context